Foghorn Therapeutics Inc. FHTX

Full chart Compare
Set alert

Price alert · FHTX

All alert types
2.13 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:01 PM EST

2.13 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

2.08 Day range 2.20
1.85 52-week range 7.07
YTD
-60.56%
1 year
-49.41%

Revenue & Expenses

Other Income → Expenses: $7.82MOther Operating Income → Expenses: $3.33MExpenses → Selling, General & Admin: $27.55MExpenses → Research & Development: $85.47MGross Profit → Expenses: $27.58MRevenue → Gross Profit: $27.58MRevenue → Cost of Revenue: $3.33MNet Loss → Expenses: $74.28MOther Income$7.82MOther Operating Income$3.33MGross Profit$27.58MNet Loss$74.28MCost of Revenue$3.33MExpenses$113.02MSelling, General & Admin$27.55MResearch & Development$85.47MRevenue$30.91M

Latest period ending Dec 31, 2025 · select a line to chart its full history

FHTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
30.91M22.60M34.16M19.23M1.32M
30.91M22.60M34.16M19.23M1.32M
-88.02M-102.68M-107.91M-117.14M-100.73M
-74.28M-86.62M-98.43M-108.88M-101.32M
-1.18-1.58-2.34-2.62-2.73
FHTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
84.13M57.16M82.04M53.92M102.87M
198.10M283.98M285.92M404.88M519.77M
306.60M329.51M363.11M404.77M422.90M
41.27M37.13M45.07M51.51M58.33M
-108.50M-45.53M-77.19M112.00K96.87M
FHTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-86.10M-100.41M-118.11M193.61M-50.25M
112.04M-29.90M144.45M-244.32M36.17M
1.02M105.43M1.78M1.76M22.42M
-50.00K-906.00K-1.22M-1.21M-3.31M
26.96M-24.88M28.12M-48.95M8.34M